Loading clinical trials...
Loading clinical trials...
A Prospective, Post-Market, Multi-Center Study Evaluating ViBone® in Cervical and Lumbar Spine Fusion
Assess clinical and radiographic outcomes in patients who undergo 1-3 level anterior cervical discectomy fusion (ACDF) or lumbar interbody fusion (TLIF, PLIF, ALIF, or LLIF) using ViBone.
This study is a prospective, multi-center study to evaluate the clinical and radiographic outcomes of ViBone in patients undergoing ACDF or lumbar interbody fusion. Data will be gathered for subjects undergoing ACDF surgery and subjects undergoing lumbar fusion surgery using ViBone. Total enrollment is expected to be approximately 100 subjects. The purpose of this study is to assess clinical and radiographic outcomes in patients who undergo 1-3 level ACDF or lumbar interbody fusion surgery using ViBone. Subjects will be followed for 12 months following surgery.
Age
18 - 80 years
Sex
ALL
Healthy Volunteers
No
Spine Institute of San Diego
San Diego, California, United States
Connecticut Neck & Back Specialists, LLC
Danbury, Connecticut, United States
Anne Arundel Medical Group
Annapolis, Maryland, United States
Orthopedic Specialists of Austin
Austin, Texas, United States
Start Date
May 14, 2018
Primary Completion Date
January 15, 2021
Completion Date
June 30, 2021
Last Updated
March 4, 2025
118
ACTUAL participants
ViBone
OTHER
Lead Sponsor
Elutia Inc.
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions